Jun 10, 2009 | Posted by: roboblogger
Celator Pharmaceuticals Presents Data on the Activity of CPX-351...
Celator Pharmaceuticals today announced that new clinical and preclinical data demonstrating the extended therapeutic bioavailability and tumor cell selectivity of CPX-351 Liposome Injection in leukemia were presented at the 14th Congress of the European Hematology Association in Berlin, Germany, June 4-7, 2009 .
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
Other Recent Cytosar-U, Cytarabine Discussions
Search the Cytosar-U, Cytarabine Forum:
Search the Cytosar-U, Cytarabine Forum:
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Bone cancer treatment ineffective, despite prom... (Nov '08) | Nov '08 | sid34 | 1 |
| FDA Grants Full Approval for DepoCyt for the Tr... (Jun '07) | Jun '07 | mike wagner | 1 |
Daily Horoscope for January 3
Sagittarius
Your stars are bright today, so make the most of it! You're on the right track and if you stick to it, you'll get a lot of recognition at the end of the day. People naturally look up to you, and it makes you feel good. An eye problem could flare up suddenly.
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
